Your blood sugar stays high despite diet and exercise. Here's the biological reason.

TCF7L2 is a transcription factor, meaning it’s a master switch that turns on and off the genes your pancreas needs to sense glucose and release insulin in response. It’s the conductor of the entire glucose-sensing orchestra. When TCF7L2 is working normally, your pancreas detects a rise in blood glucose and releases insulin within minutes, bringing levels back down.

The T allele variant of TCF7L2, present in roughly 30% of the population, impairs incretin-stimulated insulin secretion. Incretins are hormones released from your gut that tell your pancreas, “blood sugar just went up, release insulin now.” With the TCF7L2 variant, your pancreas gets the message but doesn’t respond as strongly. You release insulin, but later than you should, meaning your blood glucose spikes higher before falling again.

This creates a specific pattern: your fasting glucose might be okay, but after meals, especially carb-heavy ones, your glucose shoots up and stays elevated longer than it should. You might feel the classic blood sugar crash two hours later. Over time, this repeated spiking damages your blood vessels and forces your pancreas to work harder and harder, eventually leading to burnout and type 2 diabetes.

MTNR1B is a melatonin receptor sitting on your pancreatic beta cells. Melatonin is a hormone that tells your body it’s night and time to wind down. Part of winding down includes suppressing insulin secretion, because you’re not eating and don’t need glucose uptake. This is normal and healthy during sleep.

The G allele variant of MTNR1B, carried by roughly 30% of people, causes an exaggerated response to melatonin. Your beta cells overreact to melatonin signaling and suppress insulin secretion too much, even during the day or when it’s not appropriate. The result is chronically elevated fasting glucose, even if you ate well the day before. Your pancreas is staying in “sleep mode” too long or too intensely.

You might wake up with a fasting glucose of 105-115, which frustrates you because you didn’t eat overnight. You might also notice that late-night eating causes worse blood sugar dysregulation than morning eating of identical food. Some people with MTNR1B variants find their glucose worsens in winter months when melatonin production is naturally higher.

Inside your pancreatic beta cells, potassium channels are like gates. When glucose rises, it should cause these gates to close, building up electrical charge that triggers insulin release. KCNJ11 encodes an inward rectifier potassium channel. It’s the lock; ATP is the key. When ATP levels are high (meaning glucose has been metabolized), the key fits, the gate closes, insulin fires.

The K allele variant of KCNJ11, present in roughly 35-40% of people, makes this gate less responsive to the ATP signal. Even when glucose is high and ATP is abundant, the gate doesn’t close as readily. Your beta cells fail to generate the electrical signal needed to release insulin in response to glucose. You sense the glucose, but the final trigger never fires.

This produces a very specific problem: your blood glucose rises, your pancreas tries to respond, but insulin secretion is delayed and insufficient. You might have normal fasting glucose but severely elevated glucose two hours after eating. Your pancreas is working harder to compensate, eventually exhausting itself, which accelerates the progression to diabetes.

Insulin doesn’t exist as free-floating molecules inside your pancreatic beta cells. It’s stored in crystalline form, packed together with zinc in secretory granules. When glucose arrives, these granules release insulin into the bloodstream. SLC30A8 is a zinc transporter; it moves zinc across the cell membrane and into the secretory granules where insulin is being made.

The W allele variant of SLC30A8, carried by roughly 30% of people, reduces the efficiency of zinc transport. Your beta cells can’t get enough zinc into the granules where insulin is being packaged. Without sufficient zinc, insulin can’t crystallize properly, and secretion is impaired. You might produce normal amounts of insulin, but it’s not stored or released efficiently.

You experience this as delayed and insufficient insulin response despite adequate beta cell function. Your glucose stays elevated longer after meals. Some people with SLC30A8 variants also have issues with wound healing and immune function, because zinc is essential for those processes too.

PPARG is a receptor that regulates how your fat cells behave. It controls whether your body stores fat subcutaneously (under the skin, which is relatively healthy) or viscerally (around organs, which drives insulin resistance). PPARG also influences how your muscle and liver cells respond to the insulin signal. A fully functional PPARG promotes healthy fat storage and insulin sensitivity.

The Pro12 allele of PPARG, which is the common allele, promotes efficient subcutaneous fat storage but also impairs insulin sensitivity in muscle and liver. People carrying the Pro12 variant have a tendency toward insulin resistance that is only partially responsive to standard interventions like diet and exercise. You can eat a perfect diet and exercise regularly, and your cells still resist the insulin signal because of how your PPARG is configured. Roughly 25% of people carry this variant.

You might experience this as a plateau in weight loss despite clean eating, or difficulty improving insulin sensitivity markers despite months of low-carb dieting. Your body composition might favor fat gain over muscle. Supplementing with diet alone becomes increasingly ineffective because the problem is downstream of diet, at the receptor level.

Insulin is a messenger. It travels through the bloodstream and knocks on a receptor on your cell surface, saying “take up glucose.” But the message doesn’t stop at the receptor. It travels downstream through a relay of signaling proteins, one of which is IRS1 (insulin receptor substrate 1). IRS1 amplifies the signal and passes it deeper into the cell so that glucose transporters actually move to the cell surface and glucose enters.

The rs2943641 variant of IRS1, present in roughly 35% of people, reduces how much IRS1 your cells produce. You have fewer relay messengers to pass the insulin signal along. Even if insulin arrives and the receptor fires correctly, the downstream signal is weak, and glucose uptake into muscle and fat cells is impaired. Your cells have become resistant to insulin, but not because of obesity or diet; it’s a genetic limitation of signal transmission.

You experience this as insulin resistance that emerges despite normal weight and healthy habits. Your blood glucose stays elevated because even though insulin is present, your cells don’t respond efficiently. Over time, your pancreas cranks out more and more insulin trying to force the signal through, leading to high insulin levels, metabolic syndrome, and eventual diabetes.